USD 42.46
(-1.32%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 577.8 Million USD | 10.25% |
2022 | 524.1 Million USD | 163.68% |
2021 | 198.76 Million USD | 74.66% |
2020 | 113.79 Million USD | 95.91% |
2019 | 58.08 Million USD | -13.79% |
2018 | 67.37 Million USD | 0.45% |
2017 | 67.07 Million USD | 157.55% |
2016 | 26.04 Million USD | -1.3% |
2015 | 26.38 Million USD | 6.56% |
2014 | 24.76 Million USD | -10.41% |
2013 | 27.63 Million USD | 78.36% |
2012 | 15.49 Million USD | 5.75% |
2011 | 14.65 Million USD | -17.24% |
2010 | 17.7 Million USD | 17.75% |
2009 | 15.03 Million USD | 28.51% |
2008 | 11.7 Million USD | 6.03% |
2007 | 11.03 Million USD | 14.67% |
2006 | 9.62 Million USD | 13.24% |
2005 | 8.5 Million USD | 11.26% |
2004 | 7.64 Million USD | -19.54% |
2003 | 9.49 Million USD | -10.14% |
2002 | 10.56 Million USD | 15.54% |
2001 | 9.14 Million USD | 8.38% |
2000 | 8.43 Million USD | 0.0% |
1998 | 5.7 Million USD | -3.39% |
1997 | 5.9 Million USD | 55.26% |
1996 | 3.8 Million USD | 8.57% |
1995 | 3.5 Million USD | -28.57% |
1994 | 4.9 Million USD | 36.11% |
1993 | 3.6 Million USD | -10.0% |
1992 | 4 Million USD | 0.0% |
1991 | 4 Million USD | 5.26% |
1990 | 3.8 Million USD | 216.67% |
1989 | 1.2 Million USD | -20.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 602 Million USD | 3.24% |
2024 Q1 | 583.1 Million USD | 0.92% |
2023 Q4 | 577.8 Million USD | 4.73% |
2023 Q2 | 542.2 Million USD | 2.57% |
2023 Q1 | 528.6 Million USD | 0.86% |
2023 FY | 577.8 Million USD | 10.25% |
2023 Q3 | 551.7 Million USD | 1.75% |
2022 Q4 | 524.1 Million USD | -2.26% |
2022 FY | 524.1 Million USD | 163.68% |
2022 Q2 | 552.7 Million USD | 204.71% |
2022 Q1 | 181.38 Million USD | -8.74% |
2022 Q3 | 536.2 Million USD | -2.99% |
2021 FY | 198.76 Million USD | 74.66% |
2021 Q4 | 198.76 Million USD | 0.91% |
2021 Q1 | 174.66 Million USD | 53.49% |
2021 Q2 | 218.5 Million USD | 25.1% |
2021 Q3 | 196.97 Million USD | -9.85% |
2020 Q2 | 92.61 Million USD | 57.76% |
2020 Q4 | 113.79 Million USD | 19.51% |
2020 FY | 113.79 Million USD | 95.91% |
2020 Q1 | 58.7 Million USD | 1.07% |
2020 Q3 | 95.22 Million USD | 2.81% |
2019 Q3 | 61.74 Million USD | -4.46% |
2019 FY | 58.08 Million USD | -13.79% |
2019 Q2 | 64.62 Million USD | -3.04% |
2019 Q1 | 66.64 Million USD | -1.09% |
2019 Q4 | 58.08 Million USD | -5.92% |
2018 FY | 67.37 Million USD | 0.45% |
2018 Q1 | 57.96 Million USD | -13.59% |
2018 Q2 | 59.71 Million USD | 3.02% |
2018 Q3 | 63.3 Million USD | 6.02% |
2018 Q4 | 67.37 Million USD | 6.43% |
2017 FY | 67.07 Million USD | 157.55% |
2017 Q4 | 67.07 Million USD | 186.3% |
2017 Q1 | 22.47 Million USD | -13.73% |
2017 Q2 | 22.96 Million USD | 2.2% |
2017 Q3 | 23.42 Million USD | 2.02% |
2016 Q1 | 24.82 Million USD | -5.94% |
2016 FY | 26.04 Million USD | -1.3% |
2016 Q4 | 26.04 Million USD | 11.47% |
2016 Q3 | 23.36 Million USD | 0.98% |
2016 Q2 | 23.13 Million USD | -6.78% |
2015 FY | 26.38 Million USD | 6.56% |
2015 Q4 | 26.38 Million USD | 7.41% |
2015 Q2 | 23.68 Million USD | 3.44% |
2015 Q1 | 22.89 Million USD | -7.55% |
2015 Q3 | 24.56 Million USD | 3.75% |
2014 Q1 | 24.98 Million USD | -9.6% |
2014 Q2 | 23.52 Million USD | -5.85% |
2014 FY | 24.76 Million USD | -10.41% |
2014 Q3 | 23.51 Million USD | -0.05% |
2014 Q4 | 24.76 Million USD | 5.31% |
2013 Q1 | 20.72 Million USD | 33.72% |
2013 FY | 27.63 Million USD | 78.36% |
2013 Q4 | 27.63 Million USD | 1.02% |
2013 Q3 | 27.36 Million USD | 10.93% |
2013 Q2 | 24.66 Million USD | 19.02% |
2012 FY | 15.49 Million USD | 5.75% |
2012 Q4 | 15.49 Million USD | -8.36% |
2012 Q1 | 16.2 Million USD | 10.59% |
2012 Q2 | 17.11 Million USD | 5.6% |
2012 Q3 | 16.9 Million USD | -1.19% |
2011 Q1 | 14.83 Million USD | -16.23% |
2011 Q4 | 14.65 Million USD | -1.33% |
2011 FY | 14.65 Million USD | -17.24% |
2011 Q3 | 14.85 Million USD | -2.53% |
2011 Q2 | 15.23 Million USD | 2.71% |
2010 Q3 | 19.26 Million USD | -3.29% |
2010 Q4 | 17.7 Million USD | -8.08% |
2010 FY | 17.7 Million USD | 17.75% |
2010 Q1 | 20.52 Million USD | 36.45% |
2010 Q2 | 19.91 Million USD | -2.93% |
2009 FY | 15.03 Million USD | 28.51% |
2009 Q1 | 12.59 Million USD | 7.64% |
2009 Q2 | 11.88 Million USD | -5.61% |
2009 Q3 | 12.88 Million USD | 8.36% |
2009 Q4 | 15.03 Million USD | 16.73% |
2008 Q4 | 11.7 Million USD | 3.81% |
2008 FY | 11.7 Million USD | 6.03% |
2008 Q2 | 10.46 Million USD | -0.62% |
2008 Q3 | 11.27 Million USD | 7.69% |
2008 Q1 | 10.53 Million USD | -4.57% |
2007 Q2 | 10.23 Million USD | 14.41% |
2007 FY | 11.03 Million USD | 14.67% |
2007 Q4 | 11.03 Million USD | -4.92% |
2007 Q3 | 11.6 Million USD | 13.4% |
2007 Q1 | 8.94 Million USD | -7.04% |
2006 FY | 9.62 Million USD | 13.24% |
2006 Q1 | 8.06 Million USD | -5.07% |
2006 Q3 | 9.38 Million USD | 2.48% |
2006 Q4 | 9.62 Million USD | 2.6% |
2006 Q2 | 9.15 Million USD | 13.45% |
2005 Q1 | 6.69 Million USD | -12.33% |
2005 FY | 8.5 Million USD | 11.26% |
2005 Q4 | 8.5 Million USD | 8.75% |
2005 Q3 | 7.81 Million USD | 3.74% |
2005 Q2 | 7.53 Million USD | 12.48% |
2004 Q4 | 7.64 Million USD | -38.63% |
2004 Q3 | 12.45 Million USD | 2.62% |
2004 Q2 | 12.13 Million USD | 6.7% |
2004 Q1 | 11.37 Million USD | 19.75% |
2004 FY | 7.64 Million USD | -19.54% |
2003 Q3 | 9.02 Million USD | 3.07% |
2003 Q4 | 9.49 Million USD | 5.25% |
2003 FY | 9.49 Million USD | -10.14% |
2003 Q1 | 9.32 Million USD | -11.78% |
2003 Q2 | 8.75 Million USD | -6.1% |
2002 FY | 10.56 Million USD | 15.54% |
2002 Q4 | 10.56 Million USD | 13.58% |
2002 Q3 | 9.3 Million USD | 20.47% |
2002 Q2 | 7.72 Million USD | -2.83% |
2002 Q1 | 7.94 Million USD | -13.1% |
2001 Q4 | 9.14 Million USD | 23.65% |
2001 FY | 9.14 Million USD | 8.38% |
2001 Q2 | 6.07 Million USD | -25.34% |
2001 Q3 | 7.39 Million USD | 21.74% |
2001 Q1 | 8.13 Million USD | -3.57% |
2000 FY | 8.43 Million USD | 0.0% |
2000 Q1 | 8.63 Million USD | 0.0% |
2000 Q4 | 8.43 Million USD | -7.66% |
2000 Q2 | 8.67 Million USD | 0.43% |
2000 Q3 | 9.13 Million USD | 5.36% |
1999 Q3 | 6.6 Million USD | 13.79% |
1999 Q2 | 5.8 Million USD | 1.75% |
1999 Q1 | 5.7 Million USD | -6.56% |
1998 Q3 | 6.4 Million USD | -4.48% |
1998 Q4 | 6.1 Million USD | -4.69% |
1998 FY | 5.7 Million USD | -3.39% |
1998 Q1 | 5.9 Million USD | 22.92% |
1998 Q2 | 6.7 Million USD | 13.56% |
1997 Q1 | 3.8 Million USD | -9.52% |
1997 Q2 | 4.4 Million USD | 15.79% |
1997 FY | 5.9 Million USD | 55.26% |
1997 Q4 | 4.8 Million USD | 14.29% |
1997 Q3 | 4.2 Million USD | -4.55% |
1996 Q1 | 3.5 Million USD | -16.67% |
1996 FY | 3.8 Million USD | 8.57% |
1996 Q2 | 4.2 Million USD | 20.0% |
1996 Q3 | 4.5 Million USD | 7.14% |
1996 Q4 | 4.2 Million USD | -6.67% |
1995 Q4 | 4.2 Million USD | -10.64% |
1995 Q2 | 4.7 Million USD | -4.08% |
1995 Q3 | 4.7 Million USD | 0.0% |
1995 FY | 3.5 Million USD | -28.57% |
1995 Q1 | 4.9 Million USD | 48.48% |
1994 Q2 | 3.5 Million USD | -2.78% |
1994 Q4 | 3.3 Million USD | 6.45% |
1994 Q1 | 3.6 Million USD | -2.7% |
1994 Q3 | 3.1 Million USD | -11.43% |
1994 FY | 4.9 Million USD | 36.11% |
1993 Q3 | 3.3 Million USD | -8.33% |
1993 Q2 | 3.6 Million USD | -10.0% |
1993 Q1 | 4 Million USD | -2.44% |
1993 FY | 3.6 Million USD | -10.0% |
1993 Q4 | 3.7 Million USD | 12.12% |
1992 Q3 | 4 Million USD | 0.0% |
1992 FY | 4 Million USD | 0.0% |
1992 Q1 | 4 Million USD | -2.44% |
1992 Q2 | 4 Million USD | 0.0% |
1992 Q4 | 4.1 Million USD | 2.5% |
1991 Q1 | 3.8 Million USD | 0.0% |
1991 Q3 | 4.2 Million USD | 7.69% |
1991 Q2 | 3.9 Million USD | 2.63% |
1991 Q4 | 4.1 Million USD | -2.38% |
1991 FY | 4 Million USD | 5.26% |
1990 Q1 | 1.2 Million USD | 0.0% |
1990 FY | 3.8 Million USD | 216.67% |
1989 FY | 1.2 Million USD | -20.0% |
1989 Q1 | 1.5 Million USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Akoya Biosciences, Inc. | 17.87 Million USD | -3132.086% |
AngioDynamics, Inc. | 60.61 Million USD | -853.214% |
AtriCure, Inc. | 67.89 Million USD | -750.995% |
Avinger, Inc. | 5.29 Million USD | -10806.002% |
Azenta, Inc. | 128.19 Million USD | -350.709% |
BioLife Solutions, Inc. | 43.45 Million USD | -1229.621% |
The Cooper Companies, Inc. | 735.6 Million USD | 21.452% |
Daxor Corporation | - USD | -Infinity% |
Ekso Bionics Holdings, Inc. | 5.05 Million USD | -11341.584% |
Femasys Inc. | 667.11 Thousand USD | -86511.364% |
GlucoTrack, Inc. | - USD | -Infinity% |
Harvard Bioscience, Inc. | 24.71 Million USD | -2237.757% |
Hologic, Inc. | 679.8 Million USD | 15.004% |
ICU Medical, Inc. | 709.36 Million USD | 18.546% |
Intuitive Surgical, Inc. | 1.22 Billion USD | 52.663% |
KORU Medical Systems, Inc. | 3.48 Million USD | -16497.243% |
LeMaitre Vascular, Inc. | 52.33 Million USD | -1004.083% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | -67340.202% |
Innovative Eyewear, Inc. | 856.75 Thousand USD | -67340.202% |
Masimo Corporation | 545 Million USD | -6.018% |
Microbot Medical Inc. | - USD | -Infinity% |
Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -35627.867% |
Merit Medical Systems, Inc. | 303.87 Million USD | -90.146% |
Nephros, Inc. | 2.47 Million USD | -23292.713% |
NovoCure Limited | 38.15 Million USD | -1414.468% |
NEXGEL, Inc. | 1.31 Million USD | -43705.914% |
NEXGEL, Inc. | 1.31 Million USD | -43705.914% |
Singular Genomics Systems, Inc. | 13.57 Million USD | -4157.294% |
OraSure Technologies, Inc. | 47.61 Million USD | -1113.509% |
Pro-Dex, Inc. | 15.26 Million USD | -3684.138% |
Pulse Biosciences, Inc. | - USD | -Infinity% |
Predictive Oncology Inc. | 494.37 Thousand USD | -116775.078% |
Precision Optics Corporation, Inc. | 2.86 Million USD | -20045.741% |
Repligen Corporation | 202.32 Million USD | -185.586% |
Sanara MedTech Inc. | 4.71 Million USD | -12147.927% |
STAAR Surgical Company | 35.13 Million USD | -1544.748% |
Sharps Technology, Inc. | 1.7 Million USD | -33706.575% |
Utah Medical Products, Inc. | 9.58 Million USD | -5930.056% |
DENTSPLY SIRONA Inc. | 624 Million USD | 7.404% |
Jin Medical International Ltd. | 5.05 Million USD | -11334.483% |